Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients. Eur J Haematol. 2011 Jun; 86(6):484-7.